1. Home
  2. INOD vs EWTX Comparison

INOD vs EWTX Comparison

Compare INOD & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INOD
  • EWTX
  • Stock Information
  • Founded
  • INOD 1988
  • EWTX 2017
  • Country
  • INOD United States
  • EWTX United States
  • Employees
  • INOD N/A
  • EWTX N/A
  • Industry
  • INOD EDP Services
  • EWTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INOD Technology
  • EWTX Health Care
  • Exchange
  • INOD Nasdaq
  • EWTX Nasdaq
  • Market Cap
  • INOD 1.2B
  • EWTX 1.2B
  • IPO Year
  • INOD 1993
  • EWTX 2021
  • Fundamental
  • Price
  • INOD $39.47
  • EWTX $14.28
  • Analyst Decision
  • INOD Strong Buy
  • EWTX Buy
  • Analyst Count
  • INOD 4
  • EWTX 8
  • Target Price
  • INOD $57.50
  • EWTX $40.13
  • AVG Volume (30 Days)
  • INOD 2.3M
  • EWTX 1.1M
  • Earning Date
  • INOD 05-08-2025
  • EWTX 05-08-2025
  • Dividend Yield
  • INOD N/A
  • EWTX N/A
  • EPS Growth
  • INOD 1293.88
  • EWTX N/A
  • EPS
  • INOD 1.08
  • EWTX N/A
  • Revenue
  • INOD $202,301,000.00
  • EWTX N/A
  • Revenue This Year
  • INOD $44.28
  • EWTX N/A
  • Revenue Next Year
  • INOD $21.27
  • EWTX N/A
  • P/E Ratio
  • INOD $36.67
  • EWTX N/A
  • Revenue Growth
  • INOD 114.21
  • EWTX N/A
  • 52 Week Low
  • INOD $11.87
  • EWTX $10.60
  • 52 Week High
  • INOD $71.00
  • EWTX $38.12
  • Technical
  • Relative Strength Index (RSI)
  • INOD 54.57
  • EWTX 43.22
  • Support Level
  • INOD $37.72
  • EWTX $13.80
  • Resistance Level
  • INOD $41.57
  • EWTX $14.68
  • Average True Range (ATR)
  • INOD 2.86
  • EWTX 0.78
  • MACD
  • INOD 0.37
  • EWTX 0.08
  • Stochastic Oscillator
  • INOD 61.41
  • EWTX 29.68

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

Share on Social Networks: